Verastem (NASDAQ:VSTM) Azioni, Quote.MetaTitle.unusual-options

Verastem Oncology

Verastem

Verastem Inc

ADC Therapeutics

Akebia Therapeutics

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Benitec Biopharma

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Emergent BioSolutions

enGene Holdings

Evommune

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Gossamer Bio

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Inventiva S.A. - American Depository Shares

Inventiva

Jade Biosciences

Keros Therapeutics

Monopar Therapeutics

MapLight Therapeutics, Inc. - Common Stock

MapLight Therapeutics

Myriad Genetics

NovaBridge Biosciences - American Depositary Shares

NovaBridge Biosciences

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Regenxbio

Verastem (VSTM) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Comments

Verastem Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO